dEEGtal Insights

AI-powered EEG analysis for enhanced epilepsy diagnosis

dEEGtal is a Swiss health-tech company building AI solutions to improve care in neurology, starting with epilepsy. Founded by researchers from the EEG and Epilepsy Unit at the Hôpitaux universitaires de Genève, dEEGtal tackles a critical bottleneck in neurological emergency diagnosis. The company’s first product is a platform that supports neurologists, regardless of experience level, in managing patients from the first seizure through long-term follow-up. dEEGtal combines deep clinical credibility with execution-driven entrepreneurship, has raised CHF 1.2 million in pre-seed funding led by the Wyss Center, and is currently raising its next financing round.